Table 1.
Comparison of general clinical data of patients.
| Variable | Herpes zoster neuralgia (N = 40) | Neuralgia without HZV (N = 40) | F/χ2 | P | |
|---|---|---|---|---|---|
| PHN (N = 16) | Non-PHN (N = 24) | ||||
| Age | 69.25 ± 8.87 a | 62.13 ± 8.73 b | 61.60 ± 8.70 b | 4.683 | 0.012 |
| Sex | |||||
| Male | 6 (37.5) a | 12 (50.0) a | 19 (47.5) a | 0.654 | 0.721 |
| Female | 10 (62.5) a | 12 (50.0) a | 21 (52.50) a | ||
| NRS score | 5.75 ± 1.13 a | 4.63 ± 0.58 b | 4.90 ± 0.74 b | 10.189 | <0.001 |
| The period of initial clinical visit | |||||
| <1 d | 2 (12.5) a | 6 (25.0) a | 9 (22.5) a | 1.384 | 0.847 |
| 1∼3 d | 7 (43.8) a | 9 (37.5) a | 18 (45.0) a | ||
| >3 d | 7 (43.8) a | 9 (37.5) a | 13 (32.5) a | ||
| The surface area of skin | |||||
| <3% | 6 (37.5) a | 7 (29.2) a | 16 (40.0) a | 1.612 | 0.807 |
| 3–5% | 5 (31.3) a | 10 (41.7) a | 16 (40.0) a | ||
| >5% | 5 (31.3) a | 7 (29.2) a | 8 (20.0) a | ||
| Combined disease | |||||
| Yes | 14 (87.5) a | 19 (79.2) a | 27 (67.5) a | 2.756 | 0.252 |
| No | 2 (12.5) a | 5 (20.8) a | 13 (32.5) a | ||
PHN, postherpetic neuralgia; HZV, herpes zoster virus; P, p value; N, number; NRS, numerical rating scale; d, day. ∗Categorical variables are presented as numbers and percentages, while continuous variables are presented as mean ± standard deviation.